Bücher online kaufen
Bortezomib in the Treatment of Multiple Myeloma
-0 %
HC runder Rücken kaschiert
Print on Demand | Lieferzeit: Print on Demand - Lieferbar innerhalb von 3-5 Werktagen I
Artikel-Nr:
9783764389475
Veröffentl:
2010
Einband:
HC runder Rücken kaschiert
Erscheinungsdatum:
11.11.2010
Seiten:
188
Autor:
Irene M. Ghobrial
Gewicht:
488 g
Format:
241x160x16 mm
Serie:
Milestones in Drug Therapy
Sprache:
Englisch
Beschreibung:
Multiple Myeloma (MM) is the second most common type of blood cancer, resulting from an overproduction of cancerous infection-fighting white blood cells, known as plasma cells. Plasma cells are a crucial part of the immune system responsible for the production of antibodies. Bortezomib is a promising anticancer drug targeting the proteasome. This proteasome inhibitor induces cell stress and apoptosis in the cancer cells. While multiple mechanisms are likely to be involved, proteasome inhibition may prevent the degradation of pro-apoptotic factors, permitting activation of programmed cell death in neoplastic cells dependent upon the suppression of proapoptotic pathways.This monograph on bortezomib is a valuable source of information for researchers and clinicians from the fields of oncology and pharmacology, working either in academia or the pharmaceutical industry.
Contemporary monograph on Bortezomib and the proteasome discovery from the lab to the clinic
.